Advanced Medical Solutions Group

Advanced Medical Solutions Group

AMS.L
United Kingdom

Advanced Medical Solutions Group is a specialist in tissue-healing technologies, focusing on advanced wound care and surgical sealants. The company has built a diversified portfolio of commercial products and maintains a robust R&D pipeline to drive future growth. With a global commercial footprint and a strategy of both organic innovation and strategic acquisitions, AMS is positioned as a key player in the medical device sector, aiming to improve clinical outcomes and cost-efficiency in surgery and wound management.

AMS.L · Stock Price

USD 192.801.20 (-0.62%)
Market Cap: $559.9M

Historical price data

AI Company Overview

Advanced Medical Solutions Group is a specialist in tissue-healing technologies, focusing on advanced wound care and surgical sealants. The company has built a diversified portfolio of commercial products and maintains a robust R&D pipeline to drive future growth. With a global commercial footprint and a strategy of both organic innovation and strategic acquisitions, AMS is positioned as a key player in the medical device sector, aiming to improve clinical outcomes and cost-efficiency in surgery and wound management.

SurgeryWound CareHemostasis

Technology Platform

Specialist in developing and manufacturing tissue-healing technologies, with core expertise in liquid-applied surgical sealants (cyanoacrylates), absorbable biomaterials (collagen, gelatin, fibrin), and advanced wound care dressings.

Pipeline

2
2 drugs in pipeline
DrugIndicationStageWatch
Pro-Pe adhesive tabletUlcer, AphthousPhase 2
Pain MedicineChronic Nonmalignant PainPre-clinical

Opportunities

Significant opportunities exist in geographic expansion, particularly in the large US and growing Asian healthcare markets.
Further penetration of minimally invasive surgery and the rising prevalence of chronic wounds provide strong tailwinds for AMS's core product categories.
The company's strong balance sheet also allows for strategic acquisitions to bolt on new technologies or commercial channels.

Risk Factors

Key risks include regulatory hurdles for new products, intense pricing pressure from larger competitors, potential challenges in integrating future acquisitions, and dependency on healthcare reimbursement policies which can vary by region and are subject to change.

Competitive Landscape

AMS competes against large medical device conglomerates like Johnson & Johnson, Baxter, and BD in surgical sealants, and Smith & Nephew and Mölnlycke in wound care. Its differentiation lies in its focused expertise, value-based product portfolio, and agility as an independent specialist, allowing for targeted innovation and partnerships.